GRAIL (GRAL) Stock: Buy, Sell, or Hold?
GRAL - GRAIL, Inc. Common Stock
$132.60
7.93 (6.36%)
▲
5d:
-5.08%
30d:
+22.81%
90d:
+87.66%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026
19d
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GRAL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GRAL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $132.60, which is considered fair relative to its 30-day fair value range of $98.53 to $145.08.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $117.06, while resistance sits at $144.18. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $117.06, while resistance sits at $144.18. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$98.53 -
$145.08
Company Quality Score
55/100
(HOLD)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
Protect Your Profits
Holding GRAL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 32th percentile)
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.4%)
- NEUTRAL: Near Wall St target ($131.30)
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
- CAUTION: 5-day price weakness (-5.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$98.53 -
$145.08
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$16.17
(12.2%)
Support & Resistance Levels
Support Level
$117.06
Resistance Level
$144.18
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.07
Wall Street Target
$131.30
(-1.0%)
Revenue Growth (YoY)
25.7%
Profit Margin
-236.9%
Share & Embed Analysis
Last updated: October 21, 2026 10:01 PM ET
Data refreshes hourly during market hours. Next update: 11:01 PM
Data refreshes hourly during market hours. Next update: 11:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 61 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 42 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 44 HOLD |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
